The survival analysis showed that high CDK1 expression has lower survival probability in liver cancer patients compared to patients with low CDK1 expression and thus CDK1 was classified as unfavorable while, in cervical cancer the high expression of the same gene CDK1 was associated with relatively higher survival probability compared to low expression of CDK1. The protein level evidence of CDK1 in the liver (Figure 6E) and cervical (Figure 6G) cancer as generated by the IHC method are shown. This evidence concerns the gene CDK1 and cervical carcinoma.